No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
NMRA Neumora Therapeutics
- 10.850
- +0.350+3.33%
Close Dec 20 16:00 ET
- 10.360
- -0.490-4.52%
Post 20:01 ET
1.75BMarket Cap9.77P/E (TTM)
11.100High10.073Low1.90MVolume10.170Open10.500Pre Close20.59MTurnover2.24%Turnover RatioLossP/E (Static)161.56MShares21.00052wk High5.47P/B921.38MFloat Cap8.33052wk Low--Dividend TTM84.92MShs Float21.000Historical High--Div YieldTTM9.78%Amplitude8.330Historical Low10.812Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Catalyst Watch: Labor Pains for Amazon & Starbucks, Nasdaq Call-up for MicroStrategy and Pony AI Ratings
Neumora Therapeutics Price Target Maintained With a $30.00/Share by HC Wainwright & Co.
Watching Neumora Therapeutics; Shares See Volume To The Upside, Traders Circulate Unconfirmed Analyst Comments Saying "We Remain Buyers Into NMRA's MDD Data, Citing JNJ's Early Completion Of Phase III Aticaprant Study Efficacy And Safety Profile,...
10 Health Care Stocks With Whale Alerts In Today's Session
Positive Outlook on Neumora Therapeutics Driven by Navacaprant's Potential in MDD Treatment
Analysts' Top Healthcare Picks: Neumora Therapeutics, Inc. (NMRA), Tourmaline Bio (TRML)
Heat List
US
Overall
Symbol
Price
% Chg
No Data